+164.9%
ASML vs CLSK
+178.3%
-13.3%
-45.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CLSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.2% | +0.9% | +3.3% | +4.1% |
| 7D | +1.1% | +8.8% | -7.7% | -0.2% |
| 30D | +2.2% | -6.0% | +8.2% | +2.6% |
| 3M | -2.3% | -24.4% | +22.1% | +0.4% |
| 6M | +23.0% | +19.0% | +3.9% | +18.7% |
| YTD | +61.1% | +25.4% | +35.7% | +52.9% |
| 1Y | +129.1% | +39.8% | +89.4% | +110.9% |
| All | +164.9% | +178.3% | -13.3% | +107.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CLSK.
Daily Out/Under-Performance
Portfolio return minus CLSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CLSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling